Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

BWAY

Brainsway Ltd ADR

Apr 18 • 04:00PM ET

4.79

Dollar change -0.26
Percentage change -5.15	%

Healthcare • Medical Devices • Israel • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.25	Insider Own	-	Shs Outstand	16.62M	Perf Week	-9.62%
Market Cap	79.71M	Forward P/E	73.61	EPS next Y	0.07	Insider Trans	-	Shs Float	8.24M	Perf Month	-20.17%
Income	-4.20M	PEG	-	EPS next Q	-0.02	Inst Own	24.08%	Short Float	0.91%	Perf Quarter	-23.24%
Sales	31.79M	P/S	2.51	EPS this Y	84.12%	Inst Trans	-	Short Ratio	0.67	Perf Half Y	33.43%
Book/sh	2.50	P/B	1.91	EPS next Y	415.09%	ROA	-6.59%	Short Interest	0.07M	Perf Year	183.43%
Cash/sh	2.78	P/C	1.72	EPS next 5Y	-	ROE	-9.65%	52W Range	1.38 - 7.61	Perf YTD	-26.08%
Dividend Est.	-	P/FCF	-	EPS past 5Y	20.12%	ROI	-10.04%	52W High	-37.10%	Beta	1.19
Dividend TTM	-	Quick Ratio	5.30	Sales past 5Y	15.88%	Gross Margin	73.86%	52W Low	247.10%	ATR (14)	0.34
Dividend Ex-Date	-	Current Ratio	5.68	EPS Y/Y TTM	68.68%	Oper. Margin	-15.60%	RSI (14)	32.67	Volatility	5.78% 5.52%
Employees	106	Debt/Eq	0.01	Sales Y/Y TTM	16.96%	Profit Margin	-13.20%	Recom	1.00	Target Price	10.85
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	103.25%	Payout	-	Rel Volume	0.71	Prev Close	5.05
Sales Surprise	4.40%	EPS Surprise	100.00%	Sales Q/Q	49.66%	Earnings	Mar 06 BMO	Avg Volume	111.83K	Price	4.79
SMA20	-11.33%	SMA50	-18.78%	SMA200	1.04%	Trades		Volume	79,897	Change	-5.15%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-16-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-03-22	Initiated	Loop Capital	Buy	$15
Jul-19-21	Initiated	H.C. Wainwright	Buy	$17
Apr-20-21	Initiated	Northland Capital	Outperform	$15
May-13-19	Initiated	Raymond James	Outperform	$14
May-13-19	Initiated	Oppenheimer	Outperform
May-13-19	Initiated	Ladenburg Thalmann	Buy
May-13-19	Initiated	Cantor Fitzgerald	Overweight	$17

Apr-17-24 08:00AM	BrainsWay Expands Deep TMS Access in Israel Following Significant Increase in Reimbursement Rates (GlobeNewswire)
Apr-04-24 08:00AM	BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS to Treat Parkinson's Disease (GlobeNewswire)
Mar-28-24 08:00AM	BrainsWay Announces Positive Results in Late-Life Depression Post-Marketing Analysis (GlobeNewswire)
Mar-27-24 09:35AM	After Plunging -13.63% in 4 Weeks, Here's Why the Trend Might Reverse for Brainsway (BWAY) (Zacks)
Mar-18-24 12:00PM	All You Need to Know About Brainsway Ltd. Sponsored ADR (BWAY) Rating Upgrade to Buy (Zacks)
07:30AM	Loading…
07:30AM	BrainsWay Broadens Partnership with Katies Way Plus Through Order of an Additional 18 Deep TMS Systems (GlobeNewswire)
Mar-06-24 12:52PM	BWAY Stock Earnings: BrainsWay Beats Revenue for Q4 2023 (InvestorPlace)
07:30AM	BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights (GlobeNewswire)
Mar-05-24 08:20AM	What's in the Offing for Brainsway (BWAY) in Q4 Earnings? (Zacks)
Feb-21-24 08:00AM	BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024 (GlobeNewswire)
Feb-06-24 03:51PM	7 High-Growth Stocks to Snag for Spectacular Returns in 2024 (InvestorPlace)
Jan-25-24 08:32AM	Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January (InvestorPlace)
Jan-10-24 07:30AM	BrainsWay Initiates Clinical Evaluation of Rotational Field Deep TMS 360° Technology (GlobeNewswire)
Jan-03-24 08:50AM	Recent Price Trend in Brainsway Ltd. Sponsored ADR (BWAY) is Your Friend, Here's Why (Zacks)
Dec-27-23 09:55AM	Does Brainsway Ltd. Sponsored ADR (BWAY) Have the Potential to Rally 48.15% as Wall Street Analysts Expect? (Zacks)
09:40AM	Loading…
Dec-22-23 09:40AM	Are Medical Stocks Lagging Brainsway (BWAY) This Year? (Zacks)
07:10AM	7 Under-the-Radar Stocks Gearing Up for a 2025 Breakthrough (InvestorPlace)
Dec-19-23 07:30AM	BrainsWay Highlights Expanded Deep TMS Access with Growing Western U.S. Network (GlobeNewswire) +8.48%
Dec-14-23 08:50AM	Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks) -8.92%
Dec-11-23 09:55AM	Wall Street Analysts Predict a 68.72% Upside in Brainsway Ltd. Sponsored ADR (BWAY): Here's What You Should Know (Zacks) +5.62%
Dec-08-23 08:16AM	BrainsWay (BWAY) Strengthens South Korean Foothold With Deep TMS (Zacks)
Dec-07-23 08:00AM	BrainsWay Announces Continued Expansion of Deep TMS in South Korea (GlobeNewswire)
Nov-29-23 12:00PM	Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
Nov-28-23 01:29PM	Market Mavericks: 3 Stocks That Could Turn $10K into $100K by 2027 (InvestorPlace)
08:50AM	Here's Why Momentum in Brainsway Ltd. Sponsored ADR (BWAY) Should Keep going (Zacks)
Nov-23-23 09:55AM	How Much Upside is Left in Brainsway Ltd. Sponsored ADR (BWAY)? Wall Street Analysts Think 50.27% (Zacks)
Nov-20-23 07:30AM	Louisiana Insurer Expands Deep TMS Access for 1.9 Million Covered Lives (GlobeNewswire)
Nov-15-23 07:30AM	BrainsWay Reports Third Quarter 2023 Financial Results and Operational Highlights (GlobeNewswire) +14.87%
Nov-02-23 08:00AM	Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction (GlobeNewswire) +6.30%
Nov-01-23 08:00AM	BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023 (GlobeNewswire)
09:40AM	Loading…
Oct-24-23 09:40AM	Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-16-23 07:30AM	BrainsWay Announces Publication of Study Data on Accelerated Deep Transcranial Magnetic Stimulation (Deep TMS) for Depression (GlobeNewswire)
Oct-06-23 09:40AM	Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year? (Zacks)
Sep-27-23 08:00AM	BrainsWay Announces Presentation of Two Deep TMS Posters at Upcoming World Congress of Psychiatry (GlobeNewswire)
Sep-20-23 07:30AM	BrainsWay Broadens Access to Deep TMS for U.S. Military Service Members Through Expanded Partnership with Katies Way Plus (GlobeNewswire) +6.71%
Sep-13-23 09:40AM	Are Medical Stocks Lagging Brainsway (BWAY) This Year? (Zacks)
Sep-05-23 07:30AM	BrainsWay Forges Strategic Partnership with Treatment Provider in Northeast U.S. (GlobeNewswire) +5.40%
Aug-28-23 10:41AM	BrainsWay (BWAY) Expands Foothold in Taiwan With Deep TMS (Zacks)
09:40AM	Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-23-23 07:30AM	BrainsWay Further Expands Access to Deep TMS in Asia Pacific Region (GlobeNewswire) +5.14%
06:00AM	3 Stocks to Buy BEFORE They Become Wall Street Darlings (InvestorPlace)
Aug-09-23 07:30AM	BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights (GlobeNewswire) +8.77%
Aug-03-23 08:00AM	BrainsWay Announces Publication of Three New Deep TMS Research Publications (GlobeNewswire)
Jul-26-23 08:00AM	BrainsWay to Report Second Quarter 2023 Financial Results on August 9, 2023 (GlobeNewswire)
Jul-11-23 07:30AM	BrainsWay Accelerates International Expansion in India (GlobeNewswire) +7.36%
Jun-21-23 08:00AM	BrainsWay Announces Significant Expansion in Western and Central U.S. (GlobeNewswire)
May-23-23 07:30AM	BrainsWay Announces Appointment of Ido Marom as CFO (GlobeNewswire)
May-17-23 07:30AM	BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights (GlobeNewswire) +6.06%
May-15-23 08:00AM	BrainsWay Launches Investigator Initiated Study (IIS) Program (GlobeNewswire)
May-12-23 09:55AM	Brainsway Ltd. Sponsored ADR (BWAY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
May-03-23 08:00AM	BrainsWay to Report First Quarter 2023 Financial Results on May 17, 2023 (GlobeNewswire)
May-02-23 08:00AM	BrainsWay to Participate in Clinical TMS Society and American Psychiatric Association Meetings (GlobeNewswire)
Mar-28-23 08:00AM	BrainsWay Post-Marketing Study Confirms Substantial Clinical Benefits of Deep TMS in Treating Depression and Anxious Depression (GlobeNewswire)
Mar-15-23 07:30AM	BrainsWay Reports Fourth Quarter and Full-Year 2022 Financial Results and Operational Highlights (GlobeNewswire)
Mar-02-23 08:00AM	BrainsWay Named to Fast Companys 2023 List of the Worlds Most Innovative Companies (GlobeNewswire)
Mar-01-23 08:00AM	BrainsWay to Report Fourth Quarter and Full Year 2022 Financial Results on March 15, 2023 (GlobeNewswire)
Feb-23-23 08:00AM	BrainsWay Vice President of Medical Affairs Colleen Hanlon Honored with the 2023 International Brain Stimulation Early Career Award (GlobeNewswire) -7.50%
Feb-13-23 07:30AM	BrainsWay Announces Appointment of Hadar Levy as CEO (GlobeNewswire)
07:30AM	BrainsWay Announces Appointment of Ami Boehm as New Chairman (GlobeNewswire)
Feb-01-23 08:00AM	New Strong Sell Stocks for February 1st (Zacks)
Jan-31-23 08:00AM	Publication Analyzes Clinical Efficacy of Deep TMS in Treating Different Brain Regions Associated with Major Depressive Disorder (GlobeNewswire)
Jan-11-23 08:00AM	BrainsWay Announces Extended Private Insurance Coverage in Washington State for the Treatment of OCD and Depression Utilizing Deep TMS (GlobeNewswire)
Jan-10-23 12:27PM	Neuronetics Settles Unfair Competition Related Litigation Against BrainsWay (Benzinga)
08:00AM	BrainsWay Resolves Neuronetics Litigation (GlobeNewswire)
07:47AM	New Strong Sell Stocks for January 10th (Zacks)
Dec-13-22 09:15AM	BrainsWay Reports Open Market Stock Purchase by Board Member Yossi Ben Shalom (GlobeNewswire)
Nov-28-22 07:30AM	BrainsWay Reports Open Market Stock Purchases by Two Board Members (GlobeNewswire)
Nov-16-22 07:30AM	BrainsWay Reports Third Quarter 2022 Financial Results and Operational Highlights (GlobeNewswire) -31.56%
Nov-03-22 08:00AM	BrainsWay Announces Private Insurance Coverage from Premera Blue Cross for the Treatment of OCD Utilizing Deep TMS (GlobeNewswire)
Nov-02-22 08:00AM	BrainsWay to Report Third Quarter Financial Results on November 16, 2022 (GlobeNewswire)
Nov-01-22 08:00AM	BrainsWay Appoints Dr. Colleen A. Hanlon as Vice President of Medical Affairs (GlobeNewswire)
Oct-12-22 08:00AM	BrainsWay Launches Social Media Sweepstakes in Observance of Depression Awareness Month (GlobeNewswire)
Oct-11-22 08:00AM	BrainsWay and NOCD Launch Collaboration to Increase Awareness of OCD Treatments (GlobeNewswire) +5.14%
Sep-20-22 09:00AM	BrainsWay CEO Christopher von Jako Named Honorary Chair of NAMIWalks Silicon Valley (GlobeNewswire)
Sep-14-22 07:30AM	BrainsWay Announces Significant Private Insurance Coverage from Cigna Corporation for the Treatment of OCD Utilizing Deep TMS (GlobeNewswire)
Aug-31-22 09:00AM	BrainsWay to Present at the H.C. Wainwright Annual Global Investment Conference (GlobeNewswire) +5.33%
Aug-29-22 11:31AM	BrainsWay's Stimulation Device Scores FDA Approval For Depression Settings (Benzinga)
11:15AM	BrainsWay (BWAY) Stock Pops 10% on FDA Clearance News (InvestorPlace)
08:00AM	BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression (GlobeNewswire)
Aug-11-22 02:50PM	Despite Competition This Analyst Finds BrainsWay Attractive (Benzinga)
Aug-10-22 07:30AM	BrainsWay Reports Second Quarter 2022 Financial Results and Operational Highlights (GlobeNewswire) -17.17%
Jul-27-22 08:00AM	BrainsWay to Report Second Quarter Financial Results on August 10, 2022 (GlobeNewswire)
Jul-26-22 12:00PM	Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: Here's Why (Zacks)
Jul-13-22 09:55AM	Wall Street Analysts Believe Brainsway Ltd. Sponsored ADR (BWAY) Could Rally 159%: Here's is How to Trade (Zacks)
04:23AM	Brainsway Ltd. Sponsored ADR (BWAY) Stock Jumps 9.4%: Will It Continue to Soar? (Zacks)
Jun-28-22 08:00AM	BrainsWay Announces Insurance Coverage by Israeli Ministry of Health for the Treatment of Depression (GlobeNewswire)
Jun-22-22 08:00AM	BrainsWay to Present at the H.C. Wainwright 1st Annual Mental Health Conference (GlobeNewswire)
Jun-21-22 08:00AM	BrainsWay Announces Positive OCD Coverage Policy from Blue Cross Blue Shield® (BCBS) Licensee Highmark BCBS for Deep TMS (GlobeNewswire) +6.67%
May-11-22 07:30AM	BrainsWay Reports First Quarter 2022 Financial Results and Operational Highlights (GlobeNewswire) -8.78%
May-09-22 08:00AM	BrainsWay Appoints Eric Hirt as Vice President of U.S. Sales (GlobeNewswire) -9.26%
May-04-22 08:00AM	BrainsWay to Present Expanded Post-Marketing Clinical Research for Major Depressive Disorder at Clinical TMS Society (GlobeNewswire)
May-02-22 08:46AM	BrainsWay Launches #DontMissAnotherMoment Social Media Campaign to Promote Mental Health Awareness Month (GlobeNewswire)
Apr-27-22 08:00AM	BrainsWay to Report First Quarter Financial Results on May 11, 2022 (GlobeNewswire)
Mar-28-22 08:00AM	BrainsWay Appoints Dr. Joachim Seidel as Vice President of Corporate Development and Strategy (GlobeNewswire)
Mar-15-22 08:00AM	BrainsWay to Host Key Opinion Leader Webinar on Deep TMS Therapy for Treating Anxious Depression (GlobeNewswire)
Mar-09-22 07:30AM	BrainsWay Reports Fourth Quarter and Full-Year 2021 Financial Results and Operational Highlights (GlobeNewswire)
Mar-01-22 08:00AM	BrainsWay to Present at the 32nd Annual Oppenheimer Healthcare Conference (GlobeNewswire)
Feb-28-22 08:00AM	BrainsWay to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022 (GlobeNewswire)
Feb-23-22 08:00AM	BrainsWay Announces Publication of Results Demonstrating Efficacy of Deep TMS in Treating Anxiety Symptoms Comorbid to Depression (GlobeNewswire)
Feb-01-22 08:00AM	BrainsWay to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BWAY

Brainsway Ltd ADR

Upgrade your FINVIZ experience